Scientists announce final trial results of the world’s most advanced malaria vaccine

24 abril 2015

The first malaria vaccine candidate (RTS,S/AS01) to reach phase 3 clinical testing is partially effective against clinical disease in young African children up to 4 years after vaccination, according to final trial data. The results suggest that the vaccine could prevent a substantial number of cases of clinical malaria, especially in areas of high transmission.
http://feeds.sciencedaily.com/~r/sciencedaily/~3/eeUqZrDP8F4/150423211320.htm

Volver